Empresas›MDCX
MDCX · Medicus Pharma Ltd.
preparados farmaceuticos · CIK 0001997296
Medicus Pharma Ltd. (MDCX) cotiza en el NASDAQ y se dedica a preparados farmaceuticos. Aqui estan 2 documentos que ha presentado ante la SEC, desde 29 dic 2025. En sus informes aparecen frases que este sitio vigila: duda sustancial sobre la continuidad de la empresa y programa de venta continua de acciones (atm). Estan citadas literalmente mas abajo.
- Documentos
- 2
- Ultimo
- 12 ago 2026
recogidos hasta hoy
Informe trimestral
Todavia no se publican los trimestres de caja ni la dilucion de esta empresa: hacen falta datos de sus informes que solo se recogen de las que se siguen de cerca. Lo que ves abajo son sus documentos tal y como los presento ante la SEC.
Documentos presentados ante la SEC
2026
- 10-QInforme trimestralEDGAR
Duda sustancial sobre la continuidad de la empresaver la frase en el documento (ingles)
…or future products, each of which is critical to the realization of the Company's business plan and its future operations. This uncertainty, along with the Company's history of losses, indicates that substantial doubt exists about the Company's ability to continue as a going concern within one year after the date that the financial statements are issued. The financial statements do not include any adjustments that may be necessary should the Company be unable to continue as a going…
Programa de venta continua de acciones (ATM)ver la frase en el documento (ingles)
…repay the Company's Yorkville debenture and related interest obligations. As at June 30, 2026 the Company has $2,489,206 available to exercise in relation to the SEPA. On December 29, 2025, the Company entered into an equity distribution agreement (the "ATM Agreement") with Maxim Group LLC and Yorkville Securities LLC ("Yorkville Securities" and together with Maxim Group LLC, the "Agents") to create an at-the-market equity program (the "ATM"). Under the ATM Agreement…
2025
- CORRESPCorrespondencia con la SECEDGAR